The Churchill Hospital is a teaching hospital in Oxford, England. It is managed by the Oxford University Hospitals NHS Foundation Trust.

During the past decade, Churchill Hospital; Oxford Cancer and Haematology Centre conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Churchill Hospital; Oxford Cancer and Haematology Centre" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Celgene" with 2 trials sponsored, "Blueprint Medicines Corporation" with 1 trials sponsored, "Cell Genesys" with 1 trials sponsored and "CellCentric Ltd." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Churchill Hospital; Oxford Cancer and Haematology Centre" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Centre for Statistics in Medicine" with 1 trials as a collaborator and "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Churchill Hospital; Oxford Cancer and Haematology Centre" are "Breast Cancer" (2 trials), "Multiple Myeloma" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials), "Acute Myeloid Leukemia" (1 trials) and "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "Churchill Hospital; Oxford Cancer and Haematology Centre" in a lesser frequency.

Most popular intervention types in "Churchill Hospital; Oxford Cancer and Haematology Centre" are "Drug" (16 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (4 trials), "Cyclophosphamide" (3 trials), "Docetaxel" (3 trials), "Doxorubicin" (3 trials) and "Placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Churchill Hospital; Oxford Cancer and Haematology Centre" are 16 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Churchill Hospital; Oxford Cancer and Haematology Centre". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Churchill Hospital; Oxford Cancer and Haematology Centre, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Churchill Hospital; Oxford Cancer and Haematology Centre, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".